Micro Emerging Active

RTW Investments aposta em Apellis Pharmaceuticals

Pontuação
0,3
Velocidade
▲ 0,0
Artigos
1
Fontes
1

Resumo

An article belongs to this narrative if it discusses RTW Investments' new position in Apellis Pharmaceuticals.

Artigos Relacionados

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a …

Nasdaq · Mar 22, 2026
Bearish

Fontes

This New $193 Million Bet Targets a Biotech With $689 … Nasdaq

Cronologia

Última atualização Mar 22, 2026